newsfilter
← Latest News
Business Wire·

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

GeneDx combines clinical expertise with a phenotype-driven approach to solve complex genetic cases and deliver answers sooner GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the